Literature DB >> 32034664

2020 vision: New insights on hypoxia imaging to assess cardiac and extra-cardiac active inflammatory sarcoidosis.

Ronald G Schwartz1,2, Himabindu Vidula3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32034664     DOI: 10.1007/s12350-020-02032-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  4 in total

1.  False-positive (13)N-ammonia/(18)FDG PET for evaluation of cardiac sarcoidosis in a patient on peritoneal dialysis.

Authors:  Waddy O Gonzalez; Daniele Massera; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2015-03-12       Impact factor: 5.952

2.  Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring.

Authors:  Panithaya Chareonthaitawee; Rob S Beanlands; Wengen Chen; Sharmila Dorbala; Edward J Miller; Venkatesh L Murthy; David H Birnie; Edward S Chen; Leslie T Cooper; Roderick H Tung; Eric S White; Salvador Borges-Neto; Marcelo F Di Carli; Robert J Gropler; Terrence D Ruddy; Thomas H Schindler; Ron Blankstein
Journal:  J Nucl Cardiol       Date:  2017-10       Impact factor: 5.952

Review 3.  Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR.

Authors:  Aiden Abidov; Vasken Dilsizian; Rami Doukky; W Lane Duvall; Christopher Dyke; Michael D Elliott; Fadi G Hage; Milena J Henzlova; Nils P Johnson; Ronald G Schwartz; Gregory S Thomas; Andrew J Einstein
Journal:  J Nucl Cardiol       Date:  2018-12-20       Impact factor: 5.952

4.  18F-FMISO PET/CT detects hypoxic lesions of cardiac and extra-cardiac involvement in patients with sarcoidosis.

Authors:  Sho Furuya; Masanao Naya; Osamu Manabe; Kenji Hirata; Hiroshi Ohira; Tadao Aikawa; Kazuhiro Koyanagawa; Keiichi Magota; Ichizo Tsujino; Toshihisa Anzai; Yuji Kuge; Noriko Oyama-Manabe; Kohsuke Kudo; Tohru Shiga; Nagara Tamaki
Journal:  J Nucl Cardiol       Date:  2019-12-09       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.